- U.S. FDA 510(k) filing of next-generation Novasight system targeted for H2 2025 with U.S. commercial launch planned for early…
Investor webinar scheduled Tuesday, January 28, 2025, at 8:00 AM ESTMIAMI, Jan. 23, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS),…
ATHENS, Ga., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer Co., a Tilray Beverages craft beer brand under Tilray Brands,…
MOORESVILLE, N.C., Jan. 23, 2025 (GLOBE NEWSWIRE) -- The Hemp Doctor is thrilled to introduce its latest THCA innovation: THCA…
Eurofins CDMO Amatsiaquitaine S.A.S., the GMP manufacturer, to support Polyrizon in future commercialization efforts Raanana, Israel, Jan. 23, 2025 (GLOBE…
STAFFORD, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused…
Celebrating Decades of Dedication and Diversity in Healthcare Excellence RIYADH, Saudi Arabia, Jan. 23, 2025 (GLOBE NEWSWIRE) -- King Faisal…
The first investigational FcRn blocker to demonstrate sustained disease control over 24 weeks in antibody positive adult patients: anti-AChR+, anti-MuSK+,…
SINGAPORE, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Mediway Medical Centre is pleased to announce two significant achievements: the centre has…
Tokyo, Japan and Cambridge, UK, 23 January 2025 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings…